Literature DB >> 36149440

[Clonal hematopoiesis and solid neoplasms].

Christopher Maximilian Arends1, Frederik Damm2,3,4.   

Abstract

BACKGROUND: Clonal hematopoiesis (CH) is a premalignant state of the hematopoietic system that frequently occurs in old age and is associated with an elevated cardiovascular risk and higher overall mortality. AIM: The prevalence and clinical implications of CH in patients with solid neoplasms were examined.
MATERIAL AND METHODS: A review, summary and discussion of the recent literature was carried out.
RESULTS: CH occurs in 20-30% of patients with solid neoplasms. In the molecular diagnostics of tumor or cell-free DNA from plasma, CH mutations can be falsely interpreted as tumor mutations. CH and in particular mutations in the genes of the DNA damage repair machinery are associated with a higher risk of therapy-associated myeloid neoplasms (t-MN) following chemotherapy, radiotherapy and poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitor therapy.
CONCLUSION: CH is a frequent phenomenon in patients with solid neoplasms. It has high clinical relevance due to the associated risk of t‑MN. More research is needed for a better understanding of the role of CH in this patient collective and to derive evidence-based recommendations for action.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Cardiovascular diseases; Clonal hematopoiesis/risk factors; DNA repair; Precision medicine/oncology; Therapy-associated myeloid neoplasms

Year:  2022        PMID: 36149440     DOI: 10.1007/s00108-022-01404-x

Source DB:  PubMed          Journal:  Inn Med (Heidelb)        ISSN: 2731-7080


  51 in total

1.  TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis.

Authors:  D Bowen; M J Groves; A K Burnett; Y Patel; C Allen; C Green; R E Gale; R Hills; D C Linch
Journal:  Leukemia       Date:  2008-07-03       Impact factor: 11.528

2.  Managing Clonal Hematopoiesis in Patients With Solid Tumors.

Authors:  Kelly L Bolton; Nancy K Gillis; Catherine C Coombs; Koichi Takahashi; Ahmet Zehir; Rafael Bejar; Guillermo Garcia-Manero; Andrew Futreal; Brian C Jensen; Luis A Diaz; Dipti Gupta; Simon Mantha; Virginia Klimek; Elli Papaemmanuil; Ross Levine; Eric Padron
Journal:  J Clin Oncol       Date:  2018-11-07       Impact factor: 44.544

3.  Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life.

Authors:  Rocio Acuna-Hidalgo; Hilal Sengul; Marloes Steehouwer; Maartje van de Vorst; Sita H Vermeulen; Lambertus A L M Kiemeney; Joris A Veltman; Christian Gilissen; Alexander Hoischen
Journal:  Am J Hum Genet       Date:  2017-06-29       Impact factor: 11.025

4.  Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis.

Authors:  Christopher Maximilian Arends; Joel Galan-Sousa; Kaja Hoyer; Willy Chan; Marten Jäger; Kenichi Yoshida; Ricarda Seemann; Daniel Noerenberg; Nils Waldhueter; Helga Fleischer-Notter; Friederike Christen; Clemens A Schmitt; Bernd Dörken; Uwe Pelzer; Marianne Sinn; Tomasz Zemojtel; Seishi Ogawa; Sven Märdian; Adrian Schreiber; Annegret Kunitz; Ulrike Krüger; Lars Bullinger; Elena Mylonas; Mareike Frick; Frederik Damm
Journal:  Leukemia       Date:  2018-03-01       Impact factor: 11.528

5.  A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies.

Authors:  Steffen Boettcher; Peter G Miller; Rohan Sharma; Marie McConkey; Matthew Leventhal; Andrei V Krivtsov; Andrew O Giacomelli; Waihay Wong; Jesi Kim; Sherry Chao; Kari J Kurppa; Xiaoping Yang; Kirsten Milenkowic; Federica Piccioni; David E Root; Frank G Rücker; Yael Flamand; Donna Neuberg; R Coleman Lindsley; Pasi A Jänne; William C Hahn; Tyler Jacks; Hartmut Döhner; Scott A Armstrong; Benjamin L Ebert
Journal:  Science       Date:  2019-08-09       Impact factor: 47.728

6.  Clonal hematopoiesis is associated with improved survival in patients with metastatic colorectal cancer from the FIRE-3 trial.

Authors:  Christopher Maximilian Arends; Savvina Dimitriou; Arndt Stahler; Raphael Hablesreiter; Paulina M Strzelecka; Catarina M Stein; Marlon Tilgner; Ryunosuke Saiki; Seishi Ogawa; Lars Bullinger; Dominik P Modest; Sebastian Stintzing; Volker Heinemann; Frederik Damm
Journal:  Blood       Date:  2022-03-10       Impact factor: 22.113

7.  Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis.

Authors:  S Avagyan; J E Henninger; W P Mannherz; M Mistry; J Yoon; S Yang; M C Weber; J L Moore; L I Zon
Journal:  Science       Date:  2021-11-04       Impact factor: 47.728

Review 8.  The Clinical Management of Clonal Hematopoiesis: Creation of a Clonal Hematopoiesis Clinic.

Authors:  Kelly L Bolton; Ahmet Zehir; Ryan N Ptashkin; Minal Patel; Dipti Gupta; Robert Sidlow; Elli Papaemmanuil; Michael F Berger; Ross L Levine
Journal:  Hematol Oncol Clin North Am       Date:  2020-01-18       Impact factor: 3.722

9.  Cancer therapy shapes the fitness landscape of clonal hematopoiesis.

Authors:  Ryan N Ptashkin; Teng Gao; Ahmet Zehir; Elli Papaemmanuil; Kelly L Bolton; Lior Braunstein; Sean M Devlin; Daniel Kelly; Minal Patel; Antonin Berthon; Aijazuddin Syed; Mariko Yabe; Catherine C Coombs; Nicole M Caltabellotta; Mike Walsh; Kenneth Offit; Zsofia Stadler; Diana Mandelker; Jessica Schulman; Akshar Patel; John Philip; Elsa Bernard; Gunes Gundem; Juan E Arango Ossa; Max Levine; Juan S Medina Martinez; Noushin Farnoud; Dominik Glodzik; Sonya Li; Mark E Robson; Choonsik Lee; Paul D P Pharoah; Konrad H Stopsack; Barbara Spitzer; Simon Mantha; James Fagin; Laura Boucai; Christopher J Gibson; Benjamin L Ebert; Andrew L Young; Todd Druley; Koichi Takahashi; Nancy Gillis; Markus Ball; Eric Padron; David M Hyman; Jose Baselga; Larry Norton; Stuart Gardos; Virginia M Klimek; Howard Scher; Dean Bajorin; Eder Paraiso; Ryma Benayed; Maria E Arcila; Marc Ladanyi; David B Solit; Michael F Berger; Martin Tallman; Montserrat Garcia-Closas; Nilanjan Chatterjee; Luis A Diaz; Ross L Levine; Lindsay M Morton
Journal:  Nat Genet       Date:  2020-10-26       Impact factor: 41.307

10.  Inherited causes of clonal haematopoiesis in 97,691 whole genomes.

Authors:  Alexander G Bick; Joshua S Weinstock; Satish K Nandakumar; Charles P Fulco; Erik L Bao; Seyedeh M Zekavat; Mindy D Szeto; Xiaotian Liao; Matthew J Leventhal; Joseph Nasser; Kyle Chang; Cecelia Laurie; Bala Bharathi Burugula; Christopher J Gibson; Amy E Lin; Margaret A Taub; Francois Aguet; Kristin Ardlie; Braxton D Mitchell; Kathleen C Barnes; Arden Moscati; Myriam Fornage; Susan Redline; Bruce M Psaty; Edwin K Silverman; Scott T Weiss; Nicholette D Palmer; Ramachandran S Vasan; Esteban G Burchard; Sharon L R Kardia; Jiang He; Robert C Kaplan; Nicholas L Smith; Donna K Arnett; David A Schwartz; Adolfo Correa; Mariza de Andrade; Xiuqing Guo; Barbara A Konkle; Brian Custer; Juan M Peralta; Hongsheng Gui; Deborah A Meyers; Stephen T McGarvey; Ida Yii-Der Chen; M Benjamin Shoemaker; Patricia A Peyser; Jai G Broome; Stephanie M Gogarten; Fei Fei Wang; Quenna Wong; May E Montasser; Michelle Daya; Eimear E Kenny; Kari E North; Lenore J Launer; Brian E Cade; Joshua C Bis; Michael H Cho; Jessica Lasky-Su; Donald W Bowden; L Adrienne Cupples; Angel C Y Mak; Lewis C Becker; Jennifer A Smith; Tanika N Kelly; Stella Aslibekyan; Susan R Heckbert; Hemant K Tiwari; Ivana V Yang; John A Heit; Steven A Lubitz; Jill M Johnsen; Joanne E Curran; Sally E Wenzel; Daniel E Weeks; Dabeeru C Rao; Dawood Darbar; Jee-Young Moon; Russell P Tracy; Erin J Buth; Nicholas Rafaels; Ruth J F Loos; Peter Durda; Yongmei Liu; Lifang Hou; Jiwon Lee; Priyadarshini Kachroo; Barry I Freedman; Daniel Levy; Lawrence F Bielak; James E Hixson; James S Floyd; Eric A Whitsel; Patrick T Ellinor; Marguerite R Irvin; Tasha E Fingerlin; Laura M Raffield; Sebastian M Armasu; Marsha M Wheeler; Ester C Sabino; John Blangero; L Keoki Williams; Bruce D Levy; Wayne Huey-Herng Sheu; Dan M Roden; Eric Boerwinkle; JoAnn E Manson; Rasika A Mathias; Pinkal Desai; Kent D Taylor; Andrew D Johnson; Paul L Auer; Charles Kooperberg; Cathy C Laurie; Thomas W Blackwell; Albert V Smith; Hongyu Zhao; Ethan Lange; Leslie Lange; Stephen S Rich; Jerome I Rotter; James G Wilson; Paul Scheet; Jacob O Kitzman; Eric S Lander; Jesse M Engreitz; Benjamin L Ebert; Alexander P Reiner; Siddhartha Jaiswal; Gonçalo Abecasis; Vijay G Sankaran; Sekar Kathiresan; Pradeep Natarajan
Journal:  Nature       Date:  2020-10-14       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.